NASDAQ: LBRX

LB Pharmaceuticals Inc Common Stock

Healthcare | Biotechnology

No licensed closing price on file for LBRX. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

LB Pharmaceuticals Inc Common Stock (NASDAQ: LBRX) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 09:46 UTC.

Key facts

Charts

Charts are in the appInteractive charts for LBRX are available in Oxford Ledge.
Open LBRX in Oxford Ledge →

SEC Filings

SEC EDGAR ↗

Recent Insider Activity (last 90 days)

Source: SEC EDGAR · Filed 2026-10-13

2026-10-13Chief Financial OfficerEmplopyee Stock Option (Right to Buy)Award200,000—
2026-10-13Chief Medical OfficerEmplopyee Stock Option (Right to Buy)Award200,000—
2026-08-0310% OwnerPre-Funded Warrants (Right to Buy)Purchase286,205$10.00M

Top Institutional Holders (latest 13F)

Source: SEC EDGAR · As of 2026-Q2

Deep Track Capital, LP3,352,804$108.82M0.0%
BlackRock, Inc.2,734,305$88.74M+10.7%
RA CAPITAL MANAGEMENT, L.P.2,208,604$71.68M0.0%

View QoQ ownership changes →Full institutional ownership →

Recent 8-K Events (parsed from SEC filings)All events →

Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

2026-09-03Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →

Company news

View all →

No qualifying company news in the archive. Full tape in the platform →

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for LBRX and 5,000+ tickers.

Create a free account — keep LBRX

For your agent

GET /api/data?ticker=LBRX

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt